1887

Journal of General Virology header logo

Volume 46, Issue 1

Effect of Interferon on Mouse Leukaemia Virus (MuLV). V. Abnormal Proteins in Virions of Rauscher MuLV Produced in the Presence of Interferon Free

Abstract

SUMMARY

Interferon treatment of JLSV-6 cells chronically infected with Rauscher MuLV leads to the formation of non-infectious particles (‘interferon’ virions) containing the structural proteins coded by the and genes as well as additional virus polypeptides. The major glycoprotein detected in the control virions is gp71, but ‘interferon’ virions contain in addition an 85K mol. wt. (gp85) glucosamine-containing, fucose-deficient glycoprotein. This is recognized by antiserum to MuLV and may be related to pr85. Surface iodination of intact virions indicates that gp71 and gp85 are the two major components of the external envelope. However, whereas in control virions gp71 associates with p15E (gp90), this complex was not detected in ‘interferon’ virions. Analysis of radio-labelled (H-amino acids or iodinated) proteins from disrupted ‘interferon’ virions revealed the presence of 65K, 55K, 40K, 20K and 12K mol. wt. polypeptides which could be precipitated with antiserum against MuLV. There was a distinct difference in the patterns of incorporation of pulse-labelled H-amino acid polypeptides into virions in the presence and absence of interferon. Those polypeptides labelled in the presence of interferon and recovered in the extracellular virions in a chase with interferon appeared to have substantially fewer copies of p30 and more of pr55 polypeptide than the controls. These results indicate that in the presence of interferon there are changes in the proteolytic cleavage associated with virion assembly.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1980
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-46-1-97
1980-01-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/46/1/JV0460010097.html?itemId=/content/journal/jgv/10.1099/0022-1317-46-1-97&mimeType=html&fmt=ahah

References

  1. Aboud M., Shoor R., Salzberg S. 1978; Effect of interferon on exogenous murine leukemia virus infection. Virology 84:134–141
     [Google Scholar]
  2. Billiau A., Edy V. G., Sobis H., De Somer P. 1974; Influence of interferon on virus particle synthesis in oncornavirus carrier lines. I. Evidence for a direct effect on particle release. International Journal of Cancer 14:335–340
     [Google Scholar]
  3. Billiau A., Heremans H., Allen P. T., De Maeyer-Guignard J., De Somer P. 1977; Trapping of OnCOrnavirus particles at the surface of interferon-treated cells. Virology 73:537–542
     [Google Scholar]
  4. Billiau A., Heremans H., Allen P. T., Baron S., De Somer P. 1978; Interferon inhibits C type virus at a posttranscriptional prerelease step. Archives of Virology 57:205–220
     [Google Scholar]
  5. Bolognesi D. P., Leis J. J., Omennig V., Schafer W., Atkinson P. H. 1975; Role of carbohydrates in determining the immunochemical properties of major glycoprotein gp7i of Friend murine leukemia virus. Journal of Virology 16:1453–1463
     [Google Scholar]
  6. Bolognesi D. P., Montelaro R. C., Frank H., Schafer W. 1978; Assembly of type C oncornaviruses: a model. Science 199:183–186
     [Google Scholar]
  7. Bonner W. M., Laskey R. A. 1974; A film detection method for tritium labeled proteins and nucleic acids in polyacrylamide gels. European Journal of Biochemistry 46:83–88
     [Google Scholar]
  8. Chang E. H., Friedman R. M. 1977; A large glycoprotein of Moloney leukemia virus derived from interferon treated cells. Biochemical and Biophysical Research Communications 77:392–397
     [Google Scholar]
  9. Chang E. H., Mims S. J., Triche T. J., Friedman R. M. 1977; Interferon inhibits mouse murine leukemia virus release: an electron microscope study. Journal of General Virology 34:363–368
     [Google Scholar]
  10. Chang E. H., Jay F. T., Friedman R. M. 1978; Physical, morphological and biochemical alterations in the membrane of AKR mouse cells after interferon treatment. Proceedings of the National Academy of Sciences of the United States of America 75:1859–1863
     [Google Scholar]
  11. Duesberg P. H., Robinson H. L., Robinson W. S., Huebner R. J., Turner H. C. 1968; Proteins of ROUS sarcoma virus. Virology 36:73–86
     [Google Scholar]
  12. Famulari N. G., Buchhagen D. L., Klenk H. D., Fleissner E. 1976; Presence of murine leukemia virus envelope protein gp70 and P15E in a common polyprotein of infected cells. Journal of Virology 20:501–508
     [Google Scholar]
  13. Fan H., Macisaac P. 1978; Virus specific RNA synthesis in interferon-treated mouse cells productively infected with Moloney murine leukemia virus. Journal of Virology 27:449–452
     [Google Scholar]
  14. Friedman R. M. 1977; Antiviral activity of interferon. Bacteriological Reviews 41:543–567
     [Google Scholar]
  15. Friedman R. M., Chang E. H., Ramseur J. M., Myers M. W. 1975; Interferon directed inhibition of chronic murine leukemia virus production in cell cultures: lack of effect on intracellular viral markers. Journal of Virology 16:569–574
     [Google Scholar]
  16. Friedman R. M., Ramseur J. M. 1974; Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon. Proceedings of the National Academy of Sciences of the United States of America 71:3542–3544
     [Google Scholar]
  17. Hartley J. W., Rowe W. P. 1975; Clonal cell lines from a feral mouse embryo which lack host range restrictions for murine leukemia viruses. Virology 65:128–134
     [Google Scholar]
  18. Heron L., Hokland M., Berg K. 1978; Enhanced expression of β-microglobulin and HLA antigen on human lymphoid cells by interferon. Proceedings of the National Academy of Sciences of the United States of America 75:6215–6219
     [Google Scholar]
  19. Jamjoom G., Karshin W. L., Naso R. N., Arcement L. J., Alringhaus R. B. 1975; Proteins of RaUSCher murine leukemia virus: resolution of a 70, 000-dalton nonglycosylated polypeptide containing P30 peptide sequences. Virology 68:135–145
     [Google Scholar]
  20. Joklik W. K., Merigan T. C. 1966; Concerning the mechanism of action of interferon. Proceedings of the National Academy of Sciences of the United States of America 56:558–565
     [Google Scholar]
  21. Jungwirth C., Horak J., Bodo G., Lindner J., Schultze B. 1972; The synthesis of poxvirus-specific RNA in interferon-treated cells. Virology 48:59–70
     [Google Scholar]
  22. Kennel S. J., Lerner R. A. 1973; Isolation and characterization of plasma membrane associated immunoglobulin from cultures of human diploid lymphocytes. Journal of Molecular Biology 76:485–502
     [Google Scholar]
  23. Knight E. Jun 1975; Heterogeneity of purified mouse interferon. Journal of Biological Chemistry 250:4139–4144
     [Google Scholar]
  24. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
     [Google Scholar]
  25. Lengyel P., Leary X., Gresser I. 1973; Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells. Proceedings of the National Academy of Sciences of the United States of America 70:2785–2788
     [Google Scholar]
  26. Luftig R. B., Conscience J. F., Skoultchi A., Mcmillan P., Revel M., Ruddle F. 1977; Effect of interferon on dimethylsulfoxide stimulated Friend erythroleukemic cells: ultrastructural and biochemical study. Journal of Virology 23:799–810
     [Google Scholar]
  27. Mcgrath M., Witte O., Pincus T., Weissman I. L. 1978; Retrovirus purification: method that conserves envelope glycoprotein and maximizes infectivity. Journal of Virology 25:923–927
     [Google Scholar]
  28. Metz D. H., Esteban J. 1972; Interferon inhibits viral protein synthesis in L cells infected with vaccinia virus. Nature, London 238:385–388
     [Google Scholar]
  29. Naso R. B., Arcement L. J., Arlinghaus R. B. 1975; Biosynthesis of Rauscher leukemia viral proteins. Cell 4:31–36
     [Google Scholar]
  30. Naso R. B., Arcement L. J., Karshui W. L., Jamjoom G. A., Arlinghaus R. B. 1976; A fuCOSe deficient glycoprotein precursor to Rauscher leukemia virus gp69/7i. Proceedings of the National Academy of Sciences of the United States of America 73:2326–2330
     [Google Scholar]
  31. Pal B. K., Rov-Burman P. 1978; RNA tumor virus phosphoproteins: phosphorylation of precursors and processed polypeptides. Biochemical and Biophysical Research Communications 81:344–350
     [Google Scholar]
  32. Pinter A., Fleissner E. 1977; The presence of disulfide linked gp70-pl5E complexes in AKR murine leukemia virus. Virology 83:1417–1422
     [Google Scholar]
  33. Pitha P. M., Rowe W. P. 1977; Effect of interferon on exogenous, endogenous and chronic murine leukemia infection. In Control of Neoplasia by Modulation of the Immune System pp 361–365 Edited by Chirigos M. A. New York: Raven Press;
     [Google Scholar]
  34. Pitha P. M., Rowe W. P., Oxman M. N. 1976; Effect of interferon on exogenous, endogenous and chronic murine leukemia virus infection. Virology 70:324–338
     [Google Scholar]
  35. Pitha P. M., Staal S. P., Bolognesi D. P., Denny T. P., Rowe W. P. 1977; Effect of interferon on murine leukemia virus infection. II. Synthesis of viral components in exogenous infection. Virology 79:1–13
     [Google Scholar]
  36. Pitha P. M., Wivel N. A., Fernie B. F., Harper H. P. 1978; Effect of interferon on murine leukaemia virus infection. IV. Formation of non-infectious virus in chronically infected cells. Journal of General Virology 42:467–480
     [Google Scholar]
  37. Strand M., August J. T. 1976; Structural proteins of ribonucleic acid tumor viruses. Journal of Biological Chemistry 251:559–564
     [Google Scholar]
  38. Van Zaane D., Gielkens A. K. J., Dekker-Michielsen M. J. A., Bloemers H. P. J. 1975; Virus-Specific precursor polypeptides in cells infected with Rauscher leukemia virus. Virology 67:544–552
     [Google Scholar]
  39. Witte O. N., Tsukamoto-Adey A., Weissman I. K. 1977; Cellular maturation of oncornavirus glycoproteins: topological arrangement of precursor and product forms in cellular membranes. Virology 76:539–553
     [Google Scholar]
  40. Witte O. N., Weissman I. L. 1974; Membrane proteins of MSV-MLV: their role in virion-virion interaction in vitro . Virology 61:588–593
     [Google Scholar]
  41. Wong P. K. Y., Yuen P. H., Macleod R., Chang E. H., Myers M. W., Friedman R. M. 1977; The effect of interferon on de novo infection of Moloney leukemia virus. Cell 10:245–252
     [Google Scholar]
  42. Yeger H., Kalnins V. I., Stephenson J. R. 1978; Type C retrovirus maturation and assembly: post translational cleavage of the gag gene coded precursors polypeptide occurs at the cell membrane. Virology 89:34–44
     [Google Scholar]
  43. Yoshinaka Y., Luftig R. B. 1977; Properties of p70 proteolytic factor of murine leukemia viruses. Cell 12:709–719
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-46-1-97
Loading
Effect of Interferon on Mouse Leukaemia Virus (MuLV). V. Abnormal Proteins in Virions of Rauscher MuLV Produced in the Presence of Interferon
J. Gen. Virol. 46, 97 (1980); https://doi.org/10.1099/0022-1317-46-1-97
/content/journal/jgv/10.1099/0022-1317-46-1-97
/content/journal/jgv/10.1099/0022-1317-46-1-97
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error